Content about U.S. Securities and Exchange Commission

FORT WORTH, Texas — In a SEC filing, RadioShack last week confirmed it had recruited Michael De Fazio, one of the architects behind Duane Reade's new store formats, to help the small-box specialty retailer recapture some of its lost retail pizzazz. 

As SVP store concepts, De Fazio joins a team that includes Troy Risch, who came to RadioShack from Target as EVP operations in December, and Huey Long, formerly of Wal-Mart and now RadioShack EVP strategy and consumer insights who also signed with RadioShack in December. 

PARSIPPANY, N.J. — The consumer products division of British drug maker GlaxoSmithKline wants its voice heard at a Food and Drug Administration hearing scheduled for next year on a section in a 2009 law to regulate tobacco products that deals with smoking-cessation products, the company said Monday.

WHAT IT MEANS AND WHY IT'S IMPORTANT — Round one between Walgreens and Express Scripts may have technically been a draw, but that still means Walgreens' appeals to benefit consultants and payers are still out there. Whatever the outcome, the Walgreens-ESI scorecard certainly has drawn plenty of eyes to a title bout that has become a very public battle for patients.

NEW YORK — Former Duane Reade CFO William Tennant was sentenced to three years of probation for his securities fraud conviction in June 2010, according to published reports.

Tennant, convicted of one count of securities fraud, was sentenced by U.S. District Judge Deborah Batts in a hearing Tuesday in a Manhattan federal court.

COLORADO SPRINGS, Colo. — Global Market Development Center on Thursday announced that its 2011 HBW Conference, which will be held in Phoenix from Sept. 9 to 12, will feature the Senior Executive Conference for the sixth time.

The SEC format helps foster business development opportunities and consists of 40-minute appointments that took place in more relaxed venues than the traditional controlled casual conferences.

This year, as many as 60 member companies have registered to participate, GMDC said.

WASHINGTON — One could say that a job with the Food and Drug Administration would be the perfect way to get information about upcoming drug approvals and use it to profit handsomely from buying stock in the companies that manufacture the drugs before the information reaches the public.

Of course, the Securities and Exchange Commission would consider that illegal insider trading, as one FDA scientist recently discovered.